Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Am Soc Nephrol
2013 Oct 01;2410:1617-26. doi: 10.1681/ASN.2013010080.
Show Gene links
Show Anatomy links
SLC26A6 and NaDC-1 transporters interact to regulate oxalate and citrate homeostasis.
Ohana E
,
Shcheynikov N
,
Moe OW
,
Muallem S
.
???displayArticle.abstract???
The combination of hyperoxaluria and hypocitraturia can trigger Ca(2+)-oxalate stone formation, even in the absence of hypercalciuria, but the molecular mechanisms that control urinary oxalate and citrate levels are not understood completely. Here, we examined the relationship between the oxalate transporter SLC26A6 and the citrate transporter NaDC-1 in citrate and oxalate homeostasis. Compared with wild-type mice, Slc26a6-null mice exhibited increased renal and intestinal sodium-dependent succinate uptake, as well as urinary hyperoxaluria and hypocitraturia, but no change in urinary pH, indicating enhanced transport activity of NaDC-1. When co-expressed in Xenopus oocytes, NaDC-1 enhanced Slc26a6 transport activity. In contrast, Slc26a6 inhibited NaDC-1 transport activity in an activity dependent manner to restricted tubular citrate absorption. Biochemical and physiologic analysis revealed that the STAS domain of Slc26a6 and the first intracellular loop of NaDC-1 mediated both the physical and functional interactions of these transporters. These findings reveal a molecular pathway that senses and tightly regulates oxalate and citrate levels and may control Ca(2+)-oxalate stone formation.
Alpern,
Cell mechanisms of proximal tubule acidification.
1990, Pubmed
Alpern,
Cell mechanisms of proximal tubule acidification.
1990,
Pubmed
Alvarez,
Metabolon disruption: a mechanism that regulates bicarbonate transport.
2005,
Pubmed
Aronson,
Essential roles of CFEX-mediated Cl(-)-oxalate exchange in proximal tubule NaCl transport and prevention of urolithiasis.
2006,
Pubmed
,
Xenbase
Aronson,
Role of SLC26A6-mediated Cl⁻-oxalate exchange in renal physiology and pathophysiology.
2010,
Pubmed
Avella,
SLC26A9 stimulates CFTR expression and function in human bronchial cell lines.
2011,
Pubmed
,
Xenbase
Bertrand,
SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia.
2009,
Pubmed
Brennan,
Effect of pH on citrate reabsorption in the proximal convoluted tubule.
1988,
Pubmed
Davidovich,
The correlation between dental calculus and disturbed mineral metabolism in paediatric patients with chronic kidney disease.
2009,
Pubmed
Dorwart,
The solute carrier 26 family of proteins in epithelial ion transport.
2008,
Pubmed
Garcia-Perez,
Urinary metabolic phenotyping the slc26a6 (chloride-oxalate exchanger) null mouse model.
2012,
Pubmed
Harrison,
Causes, natural history, and incidence of salivary stones and obstructions.
2009,
Pubmed
Hess,
Citrate and calcium effects on Tamm-Horsfall glycoprotein as a modifier of calcium oxalate crystal aggregation.
1993,
Pubmed
Jiang,
Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6.
2006,
Pubmed
Knauf,
Net intestinal transport of oxalate reflects passive absorption and SLC26A6-mediated secretion.
2011,
Pubmed
Ko,
Gating of CFTR by the STAS domain of SLC26 transporters.
2004,
Pubmed
Lee,
Molecular mechanism of pancreatic and salivary gland fluid and HCO3 secretion.
2012,
Pubmed
Mancusso,
Structure and mechanism of a bacterial sodium-dependent dicarboxylate transporter.
2012,
Pubmed
Moe,
Kidney stones: pathophysiology and medical management.
2006,
Pubmed
Moe,
Dual role of citrate in mammalian urine.
2006,
Pubmed
Ohana,
Determinants of coupled transport and uncoupled current by the electrogenic SLC26 transporters.
2011,
Pubmed
Ohana,
Solute carrier family 26 member a2 (Slc26a2) protein functions as an electroneutral SOFormula/OH-/Cl- exchanger regulated by extracellular Cl-.
2012,
Pubmed
,
Xenbase
Pajor,
Molecular properties of the SLC13 family of dicarboxylate and sulfate transporters.
2006,
Pubmed
Pajor,
Sequence and functional characterization of a renal sodium/dicarboxylate cotransporter.
1995,
Pubmed
,
Xenbase
Pajor,
Sodium-coupled transporters for Krebs cycle intermediates.
1999,
Pubmed
,
Xenbase
Pajor,
Citrate transport by the kidney and intestine.
1999,
Pubmed
Qiu,
Molecular modulation of calcium oxalate crystallization by osteopontin and citrate.
2004,
Pubmed
Sekine,
Cloning, functional characterization, and localization of a rat renal Na+-dicarboxylate transporter.
1998,
Pubmed
,
Xenbase
Shcheynikov,
Coupling modes and stoichiometry of Cl-/HCO3- exchange by slc26a3 and slc26a6.
2006,
Pubmed
,
Xenbase
Shcheynikov,
Dynamic control of cystic fibrosis transmembrane conductance regulator Cl(-)/HCO3(-) selectivity by external Cl(-).
2004,
Pubmed
,
Xenbase
Sheng,
Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents.
2005,
Pubmed
Strohmaier,
Urinary stone formers with hypocitraturia and 'normal' urinary pH are at high risk for recurrence.
2012,
Pubmed
Wang,
Slc26a6 regulates CFTR activity in vivo to determine pancreatic duct HCO3- secretion: relevance to cystic fibrosis.
2006,
Pubmed
Wolffram,
Carrier-mediated transport is involved in mucosal succinate uptake by rat large intestine.
1994,
Pubmed
Wright,
Effect of pH on the transport of Krebs cycle intermediates in renal brush border membranes.
1982,
Pubmed
Zacchia,
Low urinary citrate: an overview.
2010,
Pubmed
van Geest,
Membrane topology of the Na(+)/citrate transporter CitS of Klebsiella pneumoniae by insertion mutagenesis.
2000,
Pubmed
